Dandekar Atul

US insider· US
Sign in for alerts
  • ACQUIREDT+30

    Maze Therapeutics Inc · NASDAQ

    +7,500 sh · $78.2K

    Filed 1 Oct 2026SEC Form 4view source
  • REDUCEDT+30

    Maze Therapeutics Inc · NASDAQ

    −7,500 sh · $202.9K

    Filed 1 Oct 2026SEC Form 4view source
  • REDUCEDStale

    Maze Therapeutics Inc · NASDAQ

    −391 sh · $10.6K

    Filed 4 Sept 2026SEC Form 4view source
  • REDUCEDStale

    Maze Therapeutics Inc · NASDAQ

    −3,207 sh · $83.4K

    Filed 4 Sept 2026SEC Form 4view source
  • REDUCEDStale

    Maze Therapeutics Inc · NASDAQ

    −2,800 sh · $73.9K

    Filed 4 Sept 2026SEC Form 4view source
  • REDUCEDStale

    Maze Therapeutics Inc · NASDAQ

    −36 sh · $929

    Filed 4 Sept 2026SEC Form 4view source
  • ACQUIREDStale

    Maze Therapeutics Inc · NASDAQ

    +12,500 sh

    Filed 3 Sept 2026SEC Form 4view source
  • REDUCEDStale

    Maze Therapeutics Inc · NASDAQ

    −7,500 sh · $206.8K

    Filed 31 Aug 2026SEC Form 4view source
  • ACQUIREDStale

    Maze Therapeutics Inc · NASDAQ

    +7,500 sh · $78.2K

    Filed 31 Aug 2026SEC Form 4view source